Amphastar Pharmaceuticals AMPH Treasury Stock
Treasury Stock at other companies
Other financials
Where this comes from
Reported directly by Amphastar Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:TreasuryStockValue.
The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amphastar Pharmaceuticals's treasury stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amphastar Pharmaceuticals's treasury stock?
- Amphastar Pharmaceuticals (AMPH) reported treasury stock of $438M in Q1 2026.
- How has Amphastar Pharmaceuticals's treasury stock changed year-over-year?
- Amphastar Pharmaceuticals's treasury stock increased by 27.3% year-over-year, from $343.93M to $438M.
- What is the long-term trend for Amphastar Pharmaceuticals's treasury stock?
- Over 5 years (2020 to 2025), Amphastar Pharmaceuticals's treasury stock has grown at a 27.4% compound annual growth rate (CAGR), from $121.81M to $408.15M.
- What does treasury stock mean?
- Shares repurchased by the company and held in treasury, reducing equity. Recorded at cost and presented as a negative equity component.